Breast cancer is the commonest type of cancer in women worldwide and the leading cause of mortality for females. The aim of this research is to classify the alive and death status of breast cancer patients using the Surveillance, Epidemiology, and End Results dataset. Due to its capacity to handle enormous data sets systematically, machine learning and deep learning has been widely employed in biomedical research to answer diverse classification difficulties. Pre-processing the data enables its visualization and analysis for use in making important decisions. This research presents a feasible machine learning-based approach for categorizing SEER breast cancer dataset. Moreover, a two-step feature selection method based on Variance Threshold and Principal Component Analysis was employed to select the features from the SEER breast cancer dataset. After selecting the features, the classification of the breast cancer dataset is carried out using Supervised and Ensemble learning techniques such as Ada Boosting, XG Boosting, Gradient Boosting, Naive Bayes and Decision Tree. Utilizing the train-test split and k-fold cross-validation approaches, the performance of various machine learning algorithms is examined. The accuracy of Decision Tree for both train-test split and cross validation achieved as 98%. In this study, it is observed that the Decision Tree algorithm outperforms other supervised and ensemble learning approaches for the SEER Breast Cancer dataset.
Despite advancements in detection and treatment, tuberculosis (TB), an infectious illness caused by the Mycobacterium TB bacteria, continues to pose a serious threat to world health. The TB diagnosis phase includes a patient’s medical history, physical examination, chest X-rays, and laboratory procedures, such as molecular testing and sputum culture. In artificial intelligence (AI), machine learning (ML) is an advanced study of statistical algorithms that can learn from historical data and generalize the results to unseen data. There are not many studies done on the ML algorithm that enables the prediction of treatment success for patients with pulmonary TB (PTB). The objective of this study is to identify an effective and predictive ML algorithm to evaluate the detection of treatment success in PTB patients and to compare the predictive performance of the ML models. In this retrospective study, a total of 1236 PTB patients who were given treatment under a randomized controlled clinical trial at the ICMR-National Institute for Research in Tuberculosis, Chennai, India were considered for data analysis. The multiple ML models were developed and tested to identify the best algorithm to predict the sputum culture conversion of TB patients during the treatment period. In this study, decision tree (DT), random forest (RF), support vector machine (SVM) and naïve bayes (NB) models were validated with high performance by achieving an area under the curve (AUC) of receiver operating characteristic (ROC) greater than 80%. The salient finding of the study is that the DT model was produced as a better algorithm with the highest accuracy (92.72%), an AUC (0.909), precision (95.90%), recall (95.60%) and F1-score (95.75%) among the ML models. This methodology may be used to study the precise ML model classification for predicting the treatment success of TB patients during the treatment period.
Background: In the medical field, various deep learning (DL) algorithms have been effectively used to extract valuable information from unstructured clinical text data, potentially leading to more effective outcomes. This study utilized clinical text data to classify clinical case reports into tuberculosis (TB) and non-tuberculosis (non-TB) groups using natural language processing (NLP), a pre-processing technique, and DL models. Methods: This study used 1743 open-source respiratory disease clinical text data, labeled via fuzzy matching with ICD-10 codes to create a labeled dataset. Two tokenization methods preprocessed the clinical text data, and three models were evaluated: the existing Text-CNN, the proposed Text-CNN with t-test, and Bio_ClinicalBERT. Performance was assessed using multiple metrics and validated on 228 baseline screening clinical case text data collected from ICMR–NIRT to demonstrate effective TB classification. Results: The proposed model achieved the best results in both the test and validation datasets. On the test dataset, it attained a precision of 88.19%, a recall of 90.71%, an F1-score of 89.44%, and an AUC of 0.91. Similarly, on the validation dataset, it achieved 100% precision, 98.85% recall, 99.42% F1-score, and an AUC of 0.982, demonstrating its effectiveness in TB classification. Conclusions: This study highlights the effectiveness of DL models in classifying TB cases from clinical notes. The proposed model outperformed the other two models. The TF-IDF and t-test showed statistically significant feature selection and enhanced model interpretability and efficiency, demonstrating the potential of NLP and DL in automating TB diagnosis in clinical decision settings.
14 August 2024 in Indian Journal of Medical Microbiology
There is a paucity of studies applying Generalized Estimating Equations (GEE) for longitudinal analysis of smoking cessation outcomes within the framework of a cluster randomized trial, especially among tuberculosis (TB) patients. In this study, a GEE model which accounts for repeated measures and cluster-level effects was implemented to identify factors associated with smoking cessation among TB patients. The data included 375 TB patients who were smokers and given TB treatment during 2013–2016 in Kanchipuram and Villupuram districts under a cluster randomized trial. GEE modeling provided robust, population-averaged estimates while accounting for intra-cluster correlation, confirming the sustained impact of these interventions. The model demonstrated that smoking cessation interventions, when integrated with TB treatment, had an impact on cessation outcomes in these populations.